Ruthenium complexes of 1,4-diazabutadiene ligands with a cis-RuCl2 moiety for catalytic acceptorless dehydrogenation of alcohols: DFT evidence of chemically non-innocent ligand participation

The acceptorless dehydrogenative coupling (ADC) of primary alcohols to esters by diazabutadiene-coordinated ruthenium compounds is reported. Treatment of cis-Ru(dmso)4Cl2 in acetone at 56 °C with different 1,4-diazabutadienes [p-XC6H4N[double bond, length as m-dash]C(H)(H)C[double bond, length as m-dash]NC6H4X-p; X = H, CH3, OCH3, and Cl; abbreviated as DAB-X], gives trans-Ru[κ2-N,N-DAB-X]2Cl2 as the kinetic product of substitution. Heating these products in o-xylene at 144 °C gives the thermodynamically favored cis-Ru[κ2-N,N-DAB-X]2Cl2 isomers. Electronic structure calculations confirm the greater stability of the cis diastereomer. The molecular structures for each pair of geometric isomers have been determined by X-ray diffraction analyses. Cyclic voltammetry experiments on the complexes show an oxidative response and a reductive response within 0.50 to 0.93 V and -0.76 to -1.24 V vs. SCE respectively. The cis-Ru[κ2-N,N-DAB-X]2Cl2 complexes function as catalyst precursors for the acceptorless dehydrogenative coupling of primary alcohols to H2 and homo- and cross-coupled esters. When 1,4-butanediol and 1,5-pentanediol are employed as substrates, lactones and hydroxyaldehydes are produced as the major dehydrogenation products, while secondary alcohols afforded ketones in excellent yields. The mechanism for the dehydrogenation of benzyl alcohol to benzyl benzoate and H2 using cis-Ru[κ2-N,N-DAB-H]2Cl2 (cis-1) as a catalyst precursor was investigated by DFT calculations. The data support a catalytic cycle that involves the four-coordinate species Ru[κ2-N,N-DAB-H][κ1-N-DAB-H](κ1-OCH2Ph) whose protonated κ1-diazabutadiene moiety functions as a chemically non-innocent ligand that facilitates a β-hydrogen elimination from the κ1-O-benzoxide ligand to give the corresponding hydride HRu[κ2-N,N-DAB-H][κ1-N-DAB-H](κ2-O,C-benzaldehyde). H2 production follows a Noyori-type elimination to give (H2)Ru[κ2-N,N-DAB-H][κ1-N-DAB-H](κ1-O-benzaldehyde) as an intermediate in the catalytic cycle.

Electronic and Geometric Structures of Paramagnetic Diazadiene Complexes of Lithium and Sodium

The electronic and molecular structures of the lithium and sodium complexes of 1,4-bis(2,6-diisopropylphenyl)-2,3-dimethyl-1,4-diazabutadiene (Me2DADDipp) were fully characterized by using a multi-frequency electron paramagnetic resonance (EPR) spectroscopy approach and crystallography, together with density functional theory (DFT) calculations. EPR measurements, using T1 relaxation-time-filtered pulse EPR spectroscopy, revealed the diagonal elements of the A and g tensors for the metal and ligand sites. It was found that the central metals in the lithium complexes had sizable contributions to the SOMO, whereas this contribution was less strongly observed for the sodium complex. Such strong contributions were attributed to structural specifications (e.g. geometrical data and atomic size) rather than electronic effects.

Glyoxalbis(2-methylmercaptoanil) complexes of nickel and ruthenium: radical versus non-radical states

The molecular and electronic structures of nickel(ii) and ruthenium(ii) complexes of glyoxalbis(2-methylmercaptoanil) and their reduced and oxidized analogues are reported.

Arylamino radical complexes of ruthenium and osmium: dual radical counter in a molecule

Radical and non-radical ruthenium and osmium complexes of 1-amino-9,10-anthraquinone (AqNH₂), which is defined as a molecule of dual radical counter, are disclosed. 1-Amido-9,10-anthraquinone (AqNH^-) complexes of the types trans-[Ru^II(AqNH^-)(PPh₃)₂(CO)Cl] (1), trans-[Os^II(AqNH^-)(PPh₃)₂(CO)Br] (2) and trans-[Ru^III(AqNH^-)(PPh₃)₂Cl₂] (3) were isolated. AqNH^- of 1-3 is redox active and undergoes oxidation reversibly at +(0.05-0.35) V to the 1-amino-9,10-anthraquinone radical (AqNH˙) and reduction at -(0.86-1.60) V to the 1-amido-9,10-anthrasemiquinonate anion radical (Aq^NHSQ˙^2-). The reaction of 2 with I₂ in CH₂Cl₂ afforded a crystalline AqNH˙ complex of the type trans-[Os^II(AqNH˙)(PPh₃)₂(CO)Br]⁺I₅^-·½I₂ (2⁺I₅^-·½I₂). AqNH˙ and Aq^NHSQ˙^2- complexes of the types trans-[Ru^II(AqNH˙)(PPh₃)₂(CO)Cl]⁺ (1⁺), trans-[Ru^III(AqNH˙)(PPh₃)₂Cl₂]⁺ (3⁺), trans-[Ru^II(Aq^NHSQ˙^2-)(PPh₃)₂(CO)Cl]^- (1^-) and trans-[Os^II(Aq^NHSQ˙^2-)(PPh₃)₂(CO)Br]^- (2^-) were generated chemically/electrochemically in solution. The electronic states of the complexes were authenticated by single crystal X-ray structure determinations of 1, 2·5/4 toluene, 3 and 2⁺I₅^-·½I₂, EPR spectroscopy and density functional theory (DFT) calculations. AqNH˙ instigates a 2c-3e p_π-d_π interaction and the length in 2⁺I₅^-·½I₂, 1.978(5) Å, is relatively shorter than the Os^II-NH_Aq^- length, 2.037(2) Å, while the Aq-NH˙ bond, 1.365(8) Å, is longer than the Aq-NH^- bond, 1.328(3) Å. DFT calculations predicted that the atomic spin is delocalized over the ligand backbone (1⁺, 56%) particularly in one of the p-orbitals of the nitrogen and the metal atoms of the 1⁺ and 2⁺ ions, while the spin is dominantly localized on the anthraquinone fragment of the 1^- and 2^- ions. TD DFT calculations were employed to elucidate the origins of the lower energy absorption bands of the neutral complexes. Hypsochromic shifts of the UV-vis-NIR absorption maximum during 1→1⁺, 2→2⁺ and 3→3⁺ conversions were recorded by spectroelectrochemical measurements.

Radical non-radical states of the [Ru(PIQ)] core in complexes (PIQ = 9,10-phenanthreneiminoquinone)

9,10-Phenanthreneiminosemiquinonate anion radical (PIQ˙(-)) complexes of ruthenium of types trans-[Ru(II)(PIQ˙(-))(PPh3)2(CO)Cl] () and trans-[Ru(III)(PIQ˙(-))(PPh3)2Cl2] () are reported. Reactions of and with I2 afford trans-[Ru(III)(PIQ˙(-))(PPh3)2(CO)Cl](+)I3(-)·½CH2Cl2 ((+)I3(-)·½CH2Cl2) and trans-[Ru(PIQ˙(-))2(PPh3)2(μ-Cl)3](+)I3(-)·¼I2·¼toluene) ((+)I3(-)·¼I2·¼toluene), while the reaction of with Br2 yields a 9,10-phenanthreneiminoquinone (PIQ) complex of the type mer-[Ru(III)(PIQ)(PPh3)Br3]·½CH2Cl2 (·½CH2Cl2). In comparison, the reaction of trans-[Ru(III)(PQ˙(-))(PPh3)2Cl2] (PQ), a 9,10-phenanthrenequinone (PQ) analogue of affords only trans-[Ru(III)(PQ)(PPh3)2Cl2](+)Br3(-) ((+)Br3(-)). Considering the X-ray bond parameters, EPR spectra and the atomic spin densities obtained from the density functional theory (DFT) calculations, is defined as a PIQ˙(-) (average C-O/N and C-C lengths, 1.280(2) and 1.453(3) Å) complex of ruthenium(ii) while is a neutral PIQ (average C-O, C-N, C-C and C-O/N lengths, 1.248(7), 1.284(7), 1.485(8) and 1.266(7) Å) complex of the ruthenium(iii) ion. The single crystal X-ray bond parameters proposed that (+)I3(-) (average C-O/N and C-C lengths, 1.294(8) and 1.449(9) Å) and (average C-O/N and C-C lengths, 1.289(2) and 1.447(4) Å) are PIQ˙(-) complexes of ruthenium(iii), while the (+) ion (average C-O/N and C-C lengths, 1.288 ± 0.004 and 1.450 ± 0.017 Å) is a co-facial bi-octahedral complex of ruthenium(iii). In contrast, the (+) ion is a PQ complex of the ruthenium(iii) ion. EPR spectra and the calculated atomic spin densities authenticated that the (+) ion obtained after constant potential coulometric oxidation of is a PIQ complex of ruthenium(iii), while the (-) ion is a hybrid state of [Ru(II)(PIQ˙(-))] and [Ru(III)(PIQ(2-))] states. It is observed that the PIQ˙(-) state in which spin is more localized on the nitrogen (∼38% in and ∼35% in (-) ion) is stable and the coordination of the PIQ(2-) state is not observed in this study. Redox activities, UV-vis/NIR absorption spectra and their origins and the spectroelectrochemical measurements for → (+), → (-) and (+) → (2+) conversions are analyzed.

Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate

Multidrug resistance (MDR) in cancer represents a variety of strategies employed by tumor cells to evade the beneficial cytotoxic effects of structurally different anticancer drugs and thus confers impediments to the successful treatment of cancers. Efflux of drugs by MDR protein-1, functional P-glycoprotein and elevated level of reduced glutathione confer resistance to cell death or apoptosis and thus provide a possible therapeutic target for overcoming MDR in cancer. Previously, we reported that a Schiff base ligand, potassium-N-(2-hydroxy 3-methoxy-benzaldehyde)-alaninate (PHMBA) overcomes MDR in both in vivo and in vitro by targeting intrinsic apoptotic/necrotic pathway through induction of reactive oxygen species (ROS). The present study describes the synthesis and spectroscopic characterization of a copper chelate of Schiff base, viz., copper (II)-N-(2-hydroxy-3-methoxy-benzaldehyde)-alaninate (CuPHMBA) and the underlying mechanism of cell death induced by CuPHMBA in vitro. CuPHMBA kills both the drug-resistant and sensitive cell types irrespective of their drug resistance phenotype. The cell death induced by CuPHMBA follows apoptotic pathway and moreover, the cell death is associated with intrinsic mitochondrial and extrinsic receptor-mediated pathways. Oxidative stress plays a pivotal role in the process as proved by the fact that antioxidant enzyme; polyethylene glycol conjugated-catalase completely blocked CuPHMBA-induced ROS generation and abrogated cell death. To summarize, the present work provides a compelling rationale for the future clinical use of CuPHMBA, a redox active copper chelate in the treatment of cancer patients, irrespective of their drug-resistance status.